Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
HLA-DRB1*15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer.
Therapeutic Plasma Exchange in Glucocorticosteroid-Unresponsive Patients With Clinically Isolated Syndrome.
Cloning, sequencing, expression and function of a cDNA encoding a receptor for the opioid growth factor, [Met(5)]enkephalin.
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.
Estimating a minimal clinically important difference for the EuroQol 5-dimension health status index in persons with multiple sclerosis.
PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model.
Interactions of innate and adaptive immunity in brain development and function.
The repair Schwann cell and its function in regenerating nerves.
Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis.
Diffuse astrocytoma arising within a demyelinating plaque.
Targeted mutations in Val101 and Arg27 interferon beta protein increase its transcriptional and translational activities.
Therapeutic Potential of the Modulation of Sphingosine 1 phosphate receptors.
Thalamus volume and ambulation in multiple sclerosis: a cross-sectional study.
Stratified mixture modeling for segmentation of white-matter lesions in brain MR images.
Diagnostic markers of axonal degeneration and demyelination in sensory nerve conduction.
Atypical presentation of multiple sclerosis.
The orphan G protein-coupled receptor GPR17 negatively regulates oligodendrocyte differentiation via Gαi/o and its downstream effector molecules.
Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis.
MicroRNA-146a Promotes Oligodendrogenesis in Stroke.
Multiple sclerosis in the very young: a case report and review of the literature.
MS Trust critical of guidance on multiple sclerosis.
Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
Childhood body mass index and multiple sclerosis risk: a long-term cohort study.
Epistatic effects on the phenotype of multiple sclerosis.
Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.
Pages
« first
‹ previous
…
597
598
599
600
601
602
603
604
605
…
next ›
last »